These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1482128)

  • 21. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
    J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
    Limbert M; Isert D; Klesel N; Markus A; Seeger K; Seibert G; Schrinner E
    Antimicrob Agents Chemother; 1991 Jan; 35(1):14-9. PubMed ID: 2014969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro antibacterial activity of DQ-2556 and its stability to various beta-lactamases.
    Fujimoto T; Watanabe M; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1990 Sep; 26(3):329-41. PubMed ID: 2228824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro investigation of BK-218, a new oral and parenteral cephalosporin.
    Szabó I; Barabás J; Tar A; Kiss L; Filep M; Schmidt T; Marossy K; Tóth-Martinez B; Barabás G; Hernádi F
    Antimicrob Agents Chemother; 1990 Feb; 34(2):349-54. PubMed ID: 2109582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinities of cephalosporins for penicillin-binding proteins and their antibacterial activities in the presence of human serum albumin.
    Fontana R; Ligozzi M; Cornaglia G
    Clin Microbiol Infect; 2000; 6 Suppl 3():82-3. PubMed ID: 11449662
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of the bacteriolytic and biochemical properties of ceftiolene (42980RP).
    Williamson R; Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1984 Dec; 14(6):581-93. PubMed ID: 6394571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608.
    Zurenko GE; Truesdell SE; Yagi BH; Mourey RJ; Laborde AL
    Antimicrob Agents Chemother; 1990 May; 34(5):884-8. PubMed ID: 2193625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
    Watanabe Y; Minami S; Hayashi T; Araki H; Kitayama R; Ochiai H
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages.
    Yokota T; Suzuki E; Arai K
    Drugs Exp Clin Res; 1988; 14(8):495-500. PubMed ID: 3073932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
    Hebeisen P; Heinze-Krauss I; Angehrn P; Hohl P; Page MG; Then RL
    Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penicillin-binding protein 5 as an inhibitory target of cefozopran in Enterococcus faecalis.
    Tsuchimori N; Okonogi K
    J Antimicrob Chemother; 1996 Mar; 37(3):605-9. PubMed ID: 9182117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
    Gootz T; Retsema J; Girard A; Hamanaka E; Anderson M; Sokolowski S
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1160-6. PubMed ID: 2679370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
    Markus A; Klesel N; Wollmann T; Isert D; Limbert M; Schrinner E; Seibert G; Bauernfeind A; Jungwirth R; Wilhelm R
    J Antibiot (Tokyo); 1992 Apr; 45(4):521-6. PubMed ID: 1592684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12.
    Rake JB; Newman DJ; Actor P
    J Antibiot (Tokyo); 1984 May; 37(5):572-6. PubMed ID: 6376452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
    Watanabe N; Hiruma R; Katsu K
    J Antimicrob Chemother; 1992 Nov; 30(5):633-41. PubMed ID: 1493980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cephalosporins: bacterial resistance measured by penicillin-binding proteins].
    Garrido J; López F
    Rev Med Chil; 1989 Sep; 117(9):1037-43. PubMed ID: 2519470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on penem antibiotics. II. In vitro activity of SUN5555, a new oral penem.
    Nishino T; Maeda Y; Ohtsu E; Koizuka S; Nishihara T; Adachi H; Okamoto K; Ishiguro M
    J Antibiot (Tokyo); 1989 Jun; 42(6):977-88. PubMed ID: 2661512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.